<DOC>
	<DOCNO>NCT01680172</DOCNO>
	<brief_summary>Depression common patient cancer . Current medication depression , effective , take several week take effect . Ketamine emerge drug promise cancer patient . In two reported case , single dose ketamine induce rapid moderately sustained symptom reduction depression anxiety adverse side effect . Benefit see little 1 hour sustain 30 day . This study randomize , double-blind , placebo-controlled investigation test whether single dose ketamine improve depression anxiety relative placebo patient cancer .</brief_summary>
	<brief_title>Oral Ketamine Treatment Depression Anxiety Patients With Cancer</brief_title>
	<detailed_description>Depression common patient cancer . Current antidepressant , effective , onset action least several week . Ketamine emerge drug promise cancer patient . It show potentiate opiate analgesic effect . Single dose parenteral enteral administration study medically healthy treatment-resistant depressed patient show rapid relief symptom . A recent two patient case series report rapid moderately sustained symptom reduction depression anxiety palliative care patient follow single dose oral ketamine 0.5 mg/kg , adverse effect . Benefit see little 1 hour administration sustain 30 day . These case report generate hypothesis efficacy ketamine treatment depression anxiety patient cancer . This study randomize , double-blind , placebo-controlled investigation hypothesis .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Patients cancer Outpatient status time study entry 18 year age old Life expectancy least 1 month Regular access telephone ( safety reason ) Reliable transportation followup visit Caregiver observation available 24 hour dose Histologicallyproven malignancy Depression score &gt; 11 Hospital Anxiety Depression Scale ( HADS ) Provision inform consent Able complete patient questionnaires alone assistance Able speak read English May receive psychoactive medication study i.e . opiate , except define within exclusion criterion May receive psychotherapy outside provider begin and/or course study Obvious cognitive dysfunction Mini Mental Status Exam score &lt; 20 Antidepressants start dose change within 8 week begin study study Benzodiazepines prescribe psychiatric indication start dose change within 2 week begin study enrollment Suicidal ideation suicide attempt within last year Patients current past psychosis delirium Females pregnant nursing Unable take oral medication Primary metastatic brain malignancy Gastrointestinal tract obstruction Prior adverse reaction contraindication ketamine Substance abuse dependence , define Diagnostic Statistical Manual Mental DisordersIV ( DSMIV ) criterion , within last 90 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>cancer</keyword>
	<keyword>depression</keyword>
	<keyword>anxiety</keyword>
	<keyword>palliative care</keyword>
</DOC>